Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990256607> ?p ?o ?g. }
- W1990256607 endingPage "101" @default.
- W1990256607 startingPage "93" @default.
- W1990256607 abstract "To investigate more effective chemotherapy against hormone refractory prostate cancer (HRPC) with the combination of estramustine (EM), docetaxel, and suramin. A total of 42 patients with symptomatic, progressive HRPC were included in this study. We evaluated the activity of the following schedule: EM 10 mg/kg orally daily on Days 1 to 21 every 28 days, docetaxel 70 mg/m2 IV on Day 2 every 28 days and a total doses of 2150 mg of suramin in every cycle. Treatment was continued until disease progression or excessive toxicity. Median follow-up was 23.4 months. A median of 8.8 consecutive cycles was administered per patient. In the 25 patients with lymphadenopathy, there were three (12%) complete and 18 (72%) partial responses for a measurable disease response rate of 84%. Levels of prostatic specific antigen (PSA) decreased by greater than 50% in 100% of patients and by greater than 90% in 76.2%. The median time to progression was 57 weeks and median overall survival was 132 weeks. A decline in PSA of ≥50% lasting ≥30 days was significantly associated with a prolonged median time to progression and median overall survival. Tumor volume reduction and/or antitumor treatment effects were observed in 88% of patients. A significant decrease in mean pain score from 7.8 (range, 6–10) to 2.2 (range, 0–4) (P < 0.001) was achieved in 78%. Of patients with bone metastasis, 30.5% demonstrated a partial response. The mean Eastern Cooperative Oncology Group (ECOG) performance score improved from 2.8 to 1.5 at the end of treatment period. There was no therapy-related death. The predominant toxicities were Grade 3 or 4 leukopenia in 33.3%, anemia in 21%, thrombocytopenia in 21.4%, cardiac ischemia in 4.7%, and rash in 4.7%. The combination of docetaxel, EM, and suramin is a highly effective regimen for HRPC. Although hematologic and gastrointestinal toxicities were modest, these were easily managed medically." @default.
- W1990256607 created "2016-06-24" @default.
- W1990256607 creator A5040669872 @default.
- W1990256607 date "2005-03-01" @default.
- W1990256607 modified "2023-10-02" @default.
- W1990256607 title "Combination chemotherapy with docetaxel, estramustine and suramin for hormone refractory prostate cancer" @default.
- W1990256607 cites W146517413 @default.
- W1990256607 cites W1816774827 @default.
- W1990256607 cites W1879747226 @default.
- W1990256607 cites W1885677122 @default.
- W1990256607 cites W1911989431 @default.
- W1990256607 cites W1974518923 @default.
- W1990256607 cites W1986993134 @default.
- W1990256607 cites W1989339760 @default.
- W1990256607 cites W2002827096 @default.
- W1990256607 cites W2003024052 @default.
- W1990256607 cites W2018771702 @default.
- W1990256607 cites W2024404898 @default.
- W1990256607 cites W2043368900 @default.
- W1990256607 cites W2065185355 @default.
- W1990256607 cites W2120079339 @default.
- W1990256607 cites W2151232297 @default.
- W1990256607 cites W2184174775 @default.
- W1990256607 cites W2204115562 @default.
- W1990256607 cites W2268171795 @default.
- W1990256607 cites W2268926393 @default.
- W1990256607 cites W2312064818 @default.
- W1990256607 cites W2320909684 @default.
- W1990256607 cites W2410793444 @default.
- W1990256607 cites W2412768672 @default.
- W1990256607 cites W2423950142 @default.
- W1990256607 cites W95159028 @default.
- W1990256607 doi "https://doi.org/10.1016/j.urolonc.2004.10.003" @default.
- W1990256607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15869993" @default.
- W1990256607 hasPublicationYear "2005" @default.
- W1990256607 type Work @default.
- W1990256607 sameAs 1990256607 @default.
- W1990256607 citedByCount "13" @default.
- W1990256607 countsByYear W19902566072012 @default.
- W1990256607 countsByYear W19902566072016 @default.
- W1990256607 countsByYear W19902566072019 @default.
- W1990256607 countsByYear W19902566072020 @default.
- W1990256607 crossrefType "journal-article" @default.
- W1990256607 hasAuthorship W1990256607A5040669872 @default.
- W1990256607 hasConcept C121332964 @default.
- W1990256607 hasConcept C121608353 @default.
- W1990256607 hasConcept C126322002 @default.
- W1990256607 hasConcept C126894567 @default.
- W1990256607 hasConcept C141071460 @default.
- W1990256607 hasConcept C142424586 @default.
- W1990256607 hasConcept C143998085 @default.
- W1990256607 hasConcept C170493617 @default.
- W1990256607 hasConcept C2776182878 @default.
- W1990256607 hasConcept C2776694085 @default.
- W1990256607 hasConcept C2778822529 @default.
- W1990256607 hasConcept C2779013556 @default.
- W1990256607 hasConcept C2780192828 @default.
- W1990256607 hasConcept C2780201970 @default.
- W1990256607 hasConcept C2781190966 @default.
- W1990256607 hasConcept C2781406297 @default.
- W1990256607 hasConcept C2994223898 @default.
- W1990256607 hasConcept C71924100 @default.
- W1990256607 hasConcept C87355193 @default.
- W1990256607 hasConcept C90924648 @default.
- W1990256607 hasConceptScore W1990256607C121332964 @default.
- W1990256607 hasConceptScore W1990256607C121608353 @default.
- W1990256607 hasConceptScore W1990256607C126322002 @default.
- W1990256607 hasConceptScore W1990256607C126894567 @default.
- W1990256607 hasConceptScore W1990256607C141071460 @default.
- W1990256607 hasConceptScore W1990256607C142424586 @default.
- W1990256607 hasConceptScore W1990256607C143998085 @default.
- W1990256607 hasConceptScore W1990256607C170493617 @default.
- W1990256607 hasConceptScore W1990256607C2776182878 @default.
- W1990256607 hasConceptScore W1990256607C2776694085 @default.
- W1990256607 hasConceptScore W1990256607C2778822529 @default.
- W1990256607 hasConceptScore W1990256607C2779013556 @default.
- W1990256607 hasConceptScore W1990256607C2780192828 @default.
- W1990256607 hasConceptScore W1990256607C2780201970 @default.
- W1990256607 hasConceptScore W1990256607C2781190966 @default.
- W1990256607 hasConceptScore W1990256607C2781406297 @default.
- W1990256607 hasConceptScore W1990256607C2994223898 @default.
- W1990256607 hasConceptScore W1990256607C71924100 @default.
- W1990256607 hasConceptScore W1990256607C87355193 @default.
- W1990256607 hasConceptScore W1990256607C90924648 @default.
- W1990256607 hasIssue "2" @default.
- W1990256607 hasLocation W19902566071 @default.
- W1990256607 hasLocation W19902566072 @default.
- W1990256607 hasOpenAccess W1990256607 @default.
- W1990256607 hasPrimaryLocation W19902566071 @default.
- W1990256607 hasRelatedWork W1980998207 @default.
- W1990256607 hasRelatedWork W1982864148 @default.
- W1990256607 hasRelatedWork W1990256607 @default.
- W1990256607 hasRelatedWork W2010765098 @default.
- W1990256607 hasRelatedWork W2091134364 @default.
- W1990256607 hasRelatedWork W2094999590 @default.
- W1990256607 hasRelatedWork W2155169688 @default.
- W1990256607 hasRelatedWork W2299690226 @default.
- W1990256607 hasRelatedWork W2770702948 @default.